PROCEPT Posts Strong Q1 Growth, Driven By U.S. System Sales And Procedure Expansion April 30, 2026 04:51 ET. PROCEPT BioRobotics Corporation (PRCT) reported first-quarter 2026 fin ...

PROCEPT BioRobotics has seen its share price move sharply over recent years, so the real question for you today is whether ...

Procept BioRobotics has received a second FDA investigational device exemption (IDE) to allow another randomised study of its Aquablation therapy. The regulatory clearance permits the start of a study ...

PROCEPT BioRobotics’ Aquablation may ease BPH symptoms while preserving function. Read here for a detailed investment ...

PROCEPT BIOROBO (PRCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

META: $214.48 million (5.3% of AUM) GOOGL: $171.23 million (4.2% of AUM) AMZN: $161.25 million (4.0% of AUM) NVDA: $149.51 million (3.7% of AUM) V: $137.50 million (3.4% of AUM) As of October 21, 2025 ...

Throughout the last three months, 4 analysts have evaluated PROCEPT BioRobotics (NASDAQ:PRCT), offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the ...

Full-year 2025 revenue guidance was updated to approximately $323 million, reflecting 44% growth compared to 2024. This includes US system revenue of $95 million, driven by greenfield sales and some ...

Fintel reports that on October 7, 2026, Barclays initiated coverage of PROCEPT BioRobotics (BMV:PRCT) with a Overweight recommendation. Separately, consensus target price data for the company as of ...

Develops, manufactures, and sells the AquaBeam Robotic System and Aquablation therapy for minimally invasive urologic surgery, primarily targeting benign prostatic hyperplasia (BPH). Generates revenue ...

PROCEPT BioRobotics stock (ISIN US74276L1052) closed at USD 17.16 on Nasdaq on October 2, 2026, gaining 0.82 percent from the prior close. The same-day filing expanded the board from nine to ten ...

View PROCEPT BioRobotics Corp. PRCT stock quote prices, financial information, real-time forecasts, and company news from CNN.